Condition

Palmoplantar Pustulosis (PPP) clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Xeligekimab for moderate-to-severe palmoplantar pustulosis

  This study will test whether Xeligekimab injections can reduce symptoms and improve quality of life in adults with moderate to severe palmoplantar pustulosis.

  Recruiting Phase 4 First Hospital of China Medical University · Shenyang · NCT07503652

• Ivarmacitinib for palmoplantar pustulosis (open-label, single-arm treatment)

  This trial will try the oral drug ivarmacitinib to see if it reduces pustules and other skin symptoms in adults with palmoplantar pustulosis who have not responded to at least one systemic therapy.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07270003

Related topics

Quick answers

How many Palmoplantar Pustulosis (PPP) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →